Facebook-Icon linkedin logo “Twitter-Icon” gift
Font Size

Affiliate Faculty

David Au, M.D., MPH
Adjunct Professor
VA Puget Sound Health Care System

Additional Information

jennieJennie Best, MA, PhD
Affiliate Assistant Professor
Director, Health Economics & Outcomes Research
Amylin Pharmaceuticals

Dr. Best received her PhD from the University of Washington in 2007. She is Director of Health Economics and Outcomes Research at Amylin Pharmaceuticals where she is responsible for leading teams in developing strategy and product value propositions for health economics and clinical outcomes research in the metabolic therapeutic area.



Brian Custer, MPH, PhD
Affiliate Assistant Professor

Scientist, Epidemiology and Health Policy Research
Blood Systems Research Institute, San Francisco, CA

Additional Information



Pete Fullerton, PhD, RPh
Affiliate Professor
Strategic Pharmacy Innovations

D.S. "Pete"”Fullerton has had a distinguished career in managed care, teaching and research. From 1993-2003, he served as Vice President and Assistant Vice President for Regence Blue Shield, Seattle. In 2000, he received the Blue Cross Blue Shield Association's highest award for innovative pharmacy programs. In 1998 he was one of the original developers of the drug dossier format which was later adopted by AMCP in 2000. In addition, he has been very active in the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and has served as a member of the Board of Directors.

Dr. Fullerton's academic background includes Professor of Pharmacy (affiliate) - University of Washington; Dean of Pharmacy, University of Utah; Associate Vice President and Professor of Pharmacy, Oregon State University.


o H. Goulagoulartrt, MD, MS
Acting Instructor
Seattle Cancer Care Alliance
Thoracic/Head and Neck
Department of Medicine, Division of Medical Oncology


Dr. Goulart received his MD from Federal University of Rio de Janiero, Brazil and his Masters at University of Washington. He did his residency at the National Cancer institute of Brazil and than went on to complete his Internal Medicine Residency at the University of Washington in 2007 . He was a Post-Doctoral Fellow in Hematology/Oncology at Massachuesetts General/Harvard Medical School, Boston, MA.

Additional Information

johnson Eric Johnson, MPH, PhD
Affiliate Assistant Professor, Department of Pharmacy

Dr. Johnson specializes in the design of epidemiologic studies that evaluate drug safety and describe the outcome of illness. Most of his research investigates patients with diabetes using population-based registries and insurance databases. He collaborates with investigators at the Center for Health Research at Kaiser Permanente Northwest. Dr. Johnson teaches a graduate course on pharmacoepidemiology and another on the principles of publishing clinical evidence. He began his career in epidemiology in 1991 at the U.S. Centers for Disease Control and Prevention (CDC) where he evaluated blood product safety. He earned an MPH in Health Services Research at the University of Washington in 1994 with a concentration in outcomes research. He earned his PhD in epidemiology in 1999, also at the University of Washington. Prior to joining the Department of Pharmacy, Dr. Johnson worked as an epidemiologist for the firm Epidemiology Resources, Inc. (ERI) in Newton, Massachusetts. He is currently a member of the International Society of Pharmacoepidemiology (ISPE) and the American Diabetes Association (ADA).


Pete PennacropPete Penna, PharmD
Affiliate Associate Professor
Principal and Co-Founder, Formulary Resources, LLC

Dr Penna is principal and co-founder of Formulary Resources, LLC. He has over 30 years’ experience in a variety of pharmacy settings, including hospital, retail, academia, and managed care.

Dr. Penna served as Vice President of Pharmacy at CIGNA HealthCare. He was responsible for all aspects of the pharmacy benefit for 8 million lives, including strategic planning, clinical programs, contracting, formulary processes, benefit design, mail service, etc.

Prior to his years at CIGNA, Dr. Penna was Director of Pharmacy at Group Health Cooperative of Puget Sound. He served as a member and as chair of their P and T committee for over 14 years, and directed the staff support function for the Committee. A founder and past president of the Academy of Managed Care Pharmacy, Dr. Penna continues to be an active member, and serves as its current treasurer. He has also served as the Director of The Foundation for Managed Care Pharmacy’s program to implement AMCPs Format for Formulary Submissions.
Dr. Penna received his Pharmacy Degree from the University of California in San Francisco, where he also completed his pharmacy residency training. His interests include formulary processes, pharmacoeconomics, benefit design and clinical services in managed care.


David H. Smith, PhD
Affiliate Associate Professor
Kaiser-Permanente Center for Health Research

Dr. Smith’s research focus is on the economic evaluation of medical interventions and pharmacoepidemiology. He is involved in studies analyzing prescribing behavior, medication adherence, drug use and outcomes, and FDA funded studies on drug safety. He is currently leading several industry-funded studies on the natural history (including cost and consequences) of chronic kidney disease. He is also leading an RWJ-funded investigation into financial incentives in the treatment of depression in the primary care setting.

Dr. Smith received his pharmacy degree from the University of Washington in 1990, completed a residency in General/Clinical Pharmacy, and worked as a clinical pharmacist in home care for several years. He received a Master’s in Health Services Administration (M.H.A.) in 1995, and was awarded a Ph.D. in Pharmacy Outcomes Research from the University of Washington in 1998. He is Honorary Visiting Fellow at the University of York, Centre for Health Economics, and is adjunct assistant professor at the University of Washington School of Pharmacy.
Additional Information

John WatkinsJohn Watkins, PharmD, MPH, BCPS
Affiliate Associate Professor
Formulary Manager, Premera Blue Cross

John Watkins graduated from University of Washington. He completed a combined MPH degree in Pharmacy and Health Services at University of Washington with a residency at Group Health Cooperative, where he worked as a clinical and drug information pharmacist. He is board certified in pharmacotherapy.

John has managed the formulary process at Premera Blue Cross since 2000. He led Premera’s Biotechnology Initiative and is currently implementing the Premera Value-based Formulary.

John is a member of the AMCP Format Executive Committee, FMCP Research Committee, ISPOR North America HTA Council and ISPOR Personalized Medicine Core group.